JMB

eISSN 1738-8872
pISSN 1017-7825

Table. 1.

Table. 1.

Approved monoclonal antibodies.

Name Sponsor Approval
REGEN-COV (casirivimab and imdevimab) Regeneron EUA (November 2020)
Bamlanivimab and etesevimab Eli Lilly EUA (February 2021)
Sotrovimab GSK and Vir Biotechnology EUA (May 2021)
Regdanvimab Celltrion EUA in South Korea (February 2021)
J. Microbiol. Biotechnol. 2022;32:1~5 https://doi.org/10.4014/jmb.2110.10029
© J. Microbiol. Biotechnol.